Search

everythinglearnresearchcommunity

for

Search:↓

The topical solution increased hair count but wasn't significantly better than placebo in other measures.

Stopping erlotinib improved severe hair loss and skin issues in a patient.

Setipiprant may reduce inflammation by blocking an enzyme called aldose reductase.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Bimatoprost is safe and effective for treating eyelash loss caused by chemotherapy.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

Finasteride may affect PNMT, causing side effects.

Microneedling and oral tranexamic acid both improve facial melasma, but microneedling shows more sustained benefits.

Low-level laser therapy reduces symptoms and inflammation in frontal fibrosing alopecia.

New and repurposed treatments are improving outcomes in dermatology.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Ritlecitinib is safe and may effectively treat alopecia areata.

Ivarmacitinib effectively regrows hair in severe alopecia areata.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

Lipid nanoparticles improve treatment delivery and are key to future therapies, but challenges in manufacturing and safety remain.

Sodium valproate reduced seizures in many patients with resistant epilepsy.

ITK inhibitors may effectively treat alopecia areata.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.